(Q31072283)

28 June 2017

title

The effect of TGF-beta receptor binding peptides on smooth muscle cells (English)

1 reference

28 June 2017

Ingrid N Michon

1

1 reference

28 June 2017

Louis C Penning

2

1 reference

28 June 2017

Tom J M Molenaar

3

1 reference

28 June 2017

Theo J C van Berkel

4

1 reference

28 June 2017

Erik A L Biessen

5

1 reference

28 June 2017

Johan Kuiper

6

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Biochemical and Biophysical Research Communications

28 June 2017

published in

1 reference

28 June 2017

volume

293

1 reference

28 June 2017

issue

4

1 reference

28 June 2017

page(s)

1279-1286

1 reference

Current concepts of the pathogenesis of the acute coronary syndromes

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Vascular cell apoptosis in remodeling, restenosis, and plaque rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

The restenosis paradigm revisited: an alternative proposal for cellular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Molecular biology and post-angioplasty restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Transforming growth factor-beta: a local or systemic mediator of plaque stability?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Expression of IGF-1, IGF-1 receptor and TGF-beta following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: an immunocytochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

In vivo effect of TGF- beta 1. Enhanced intimal thickening by administration of TGF- beta 1 in rabbit arteries injured with a balloon catheter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Production of transforming growth factor beta 1 during repair of arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Osteogenic protein-1, a bone morphogenic protein member of the TGF-beta superfamily, shares chemotactic but not fibrogenic properties with TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Bifunctional effects of transforming growth factor-beta on migration of cultured rat aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Selection of peptides that bind to plasminogen activator inhibitor 1 (PAI-1) using random peptide phage-display libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Real time quantitative PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Identification of a chemotactic epitope in human transforming growth factor‐β1 spanning amino acid residues 368–374

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Mutational analysis of a transforming growth factor-beta receptor binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Distinct functional domains of TGF-beta bind receptors on endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

How cells read TGF-beta signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Identification of a structural domain that distinguishes the actions of the type 1 and 2 isoforms of transforming growth factor beta on endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Characterization of distinct functional domains of transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

An active site of transforming growth factor-beta(1) for growth inhibition and stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

Transforming growth factor beta peptide antagonists and their conversion to partial agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900378-9

10.1016/S0006-291X(02)00378-9

7 January 2021

Identifiers

DOI

1 reference

28 June 2017

1 reference